Childhood bacterial respiratory diseases: past, present, and future
Related Experiment Video
Updated: Jun 18, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Hanna Nohynek1, Shabir Madhi, Carlos G Grijalva
1National Institute for Health and Welfare, Helsinki, Finland. hanna.nohynek@thl.fi
Insights
Pneumonia remains a global child survival challenge, despite vaccines for common infections. Further research and interventions, especially vaccines, are critical to reduce childhood pneumonia mortality.
Area of Science:
- Global Health
- Pediatrics
- Infectious Diseases
Background:
- Pneumonia is a leading cause of acute respiratory infection and a significant threat to child survival worldwide.
- While vaccines have reduced some major infectious diseases, bacterial pneumonia, including severe cases, persists as a public health issue globally.
- Childhood mortality and morbidity from pneumonia are influenced by various risk factors.
Purpose of the Study:
- To examine the causes of global childhood mortality.
- To analyze the distribution of childhood pneumonia mortality and morbidity.
- To review available vaccines and their effectiveness in reducing childhood bacterial respiratory diseases.
Main Methods:
- Review of published literature on vaccines for bacterial respiratory diseases.
- Analysis of global childhood mortality data.
- Examination of risk factors for pneumonia incidence.
Main Results:
- Vaccination has reduced incidence of major bacterial and viral respiratory infections like Hib and pneumococcal disease.
- Bacterial pneumonia, particularly severe forms requiring hospitalization, continues to be a challenge in both low-resource and high-income countries.
- Vaccines are critical interventions for reducing childhood mortality, offering rapid, feasible, and sustained impact.
Conclusions:
- Further epidemiologic studies are needed to identify the full disease burden of pneumonia.
- Urgent implementation of proven, cost-effective interventions, especially vaccines, is necessary to reduce childhood mortality.
- Vaccines play a critical role in public health strategies aimed at achieving Millennium Development Goals for child survival.
Abstract:
Pneumonia is the most serious acute respiratory infection and is caused by numerous etiologic agents, bacteria and viruses. Severe pneumonia is a major challenge to survival of children globally. In this article we examine the causes of global childhood mortality, and the distribution of childhood pneumonia mortality and morbidity, as well as the risk factors that affect pneumonia incidence. Although major bacterial and viral respiratory infections, such as diphtheria, measles, Haemophilus influenzae type b (Hib), and pneumococcal infections, are now preventable through vaccination, bacterial pneumonia, including severe pneumonia (those that require hospitalization), still remain a public health challenge in both resource-poor and wealthy countries. We therefore, review the published literature on the available vaccines and their potential effectiveness in further reducing the burden of childhood bacterial respiratory diseases. There is a need to conduct further epidemiologic studies for identifying the disease burden and for urgent implementation of proven cost-effective interventions. These interventions are a necessary part of public health actions to reduce childhood mortality, a major Millennium Development Goal. The role of vaccines in this regard is critical, as they represent a rapid and feasible intervention with an early and sustained impact.
Related Concept Videos
Microbiota of the Respiratory Tract
Asthma I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Respiratory Syncytial Virus Disease
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
